194032-16-1 Usage
Description
5-Chlorosulfonyl-4-methylisoquinoline, with the CAS number 194032-16-1, is a light yellow to tan solid compound that is primarily utilized in the field of organic synthesis. It is a derivative of isoquinoline, a heterocyclic organic compound with a fused benzene and pyridine ring structure. The presence of the chlorosulfonyl group and the methyl group at specific positions on the isoquinoline ring endow this compound with unique chemical properties and reactivity, making it a valuable intermediate in the synthesis of various organic molecules.
Uses
Used in Organic Synthesis:
5-Chlorosulfonyl-4-methylisoquinoline is used as a synthetic intermediate for the preparation of various organic compounds. Its unique chemical structure allows it to be a versatile building block in the synthesis of complex organic molecules, including pharmaceuticals, agrochemicals, and other specialty chemicals. The compound's reactivity can be exploited to form a wide range of products through various chemical reactions, such as substitution, addition, and condensation reactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-Chlorosulfonyl-4-methylisoquinoline is used as a key intermediate in the synthesis of various drug candidates. Its unique chemical properties enable the development of novel therapeutic agents with potential applications in the treatment of various diseases and medical conditions. The compound's reactivity and structural diversity make it an attractive starting material for the design and synthesis of new drugs with improved efficacy, safety, and pharmacokinetic profiles.
Used in Agrochemical Industry:
5-Chlorosulfonyl-4-methylisoquinoline is also utilized in the agrochemical industry for the synthesis of various agrochemical products, such as pesticides and herbicides. Its unique chemical structure and reactivity make it a valuable intermediate for the development of new and effective crop protection agents. These agents can help improve crop yield and quality by controlling pests, diseases, and weeds, ultimately contributing to global food security.
Used in Dye and Pigment Industry:
In the dye and pigment industry, 5-Chlorosulfonyl-4-methylisoquinoline can be used as a starting material for the synthesis of various organic dyes and pigments. Its unique chemical properties and reactivity enable the development of novel colorants with improved color strength, stability, and fastness properties. These dyes and pigments can be used in various applications, such as textiles, plastics, inks, and coatings, to impart vibrant and long-lasting colors to various materials.
Used in Research and Development:
5-Chlorosulfonyl-4-methylisoquinoline is also used in research and development laboratories for the synthesis and evaluation of new organic compounds and materials. Its unique chemical structure and reactivity make it an attractive candidate for the development of novel organic molecules with potential applications in various fields, such as pharmaceuticals, materials science, and nanotechnology. Researchers can use this compound to explore new reaction pathways, develop innovative synthetic strategies, and gain insights into the structure-property relationships of various organic systems.
Check Digit Verification of cas no
The CAS Registry Mumber 194032-16-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,0,3 and 2 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 194032-16:
(8*1)+(7*9)+(6*4)+(5*0)+(4*3)+(3*2)+(2*1)+(1*6)=121
121 % 10 = 1
So 194032-16-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H8ClNO2S/c1-7-5-12-6-8-3-2-4-9(10(7)8)15(11,13)14/h2-6H,1H3
194032-16-1Relevant articles and documents
ROCK KINASE INHIBITORS
-
, (2020/05/29)
The present invention relates to compounds that inhibit ROCK activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of inhibiting ROCK activity and methods for treating, for example cerebral cavernous malformation syndrome (CCM) and cardiovascular diseases using the compounds and pharmaceutical compositions of the present invention.
